- Home
- ASND vs QXO Comparison
ASND vs QXO Comparison
Compare ASND & QXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ASND | QXO |
|---|---|---|
| Founded | 2006 | 1988 |
| Country | Denmark | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.6B | 19.0B |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | ASND | QXO |
|---|---|---|
| Price | $244.29 | $22.05 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 15 | 13 |
| Target Price | ★ $277.13 | $33.17 |
| AVG Volume (30 Days) | 751.3K | ★ 6.5M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $98.99 | $12,065.70 |
| Revenue Next Year | $41.45 | $62.44 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $124.06 | $11.97 |
| 52 Week High | $242.43 | $27.61 |
Technical Indicators
Market Signals| Indicator | ASND | QXO |
|---|---|---|
| Relative Strength Index (RSI) | 64.32 | 38.95 |
| Support Level | $190.49 | $20.58 |
| Resistance Level | N/A | $21.97 |
| Average True Range (ATR) | 10.44 | 1.22 |
| MACD | 1.37 | -0.44 |
| Stochastic Oscillator | 83.07 | 6.74 |
Price Performance
Historical ComparisonAbout ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.
About QXO QXO Inc.
QXO Inc is the publicly traded distributor of roofing, waterproofing and complementary building products in the United States. The company aims to become the tech-enabled leader in the approximately $800 billion building products distribution industry and generate outsized value for shareholders. It is targeting nearly $50 billion in annual revenues within the next decade through accretive acquisitions and organic growth.